http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101865868-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C55-07 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C55-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41 |
| filingDate | 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101865868-B1 |
| titleOfInvention | Process for large scale production of 1-isopropyl-3-[5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl]-1h-indazole oxalate |
| abstract | The present invention relates to the use of 1-isopropyl-3 (1) compounds of formula (I) as selective 5-HT 4 receptor ligands for the symptomatic treatment of memory and cognitive disorders such as Alzheimer's disease and attention deficit hyperactivity disorder, Parkinsonian syndrome and schizophrenia. - {5- [1- (3-methoxypropyl) piperidin-4-yl] - [1,3,4] oxadiazol-2-yl} -1H-indazole oxalate To a method suitable for the following. |
| priorityDate | 2014-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.